Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Dr Agarwals Eye Hospital Ltd (DRAGARWQ)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 526783 NSE: DRAGARWQ Hospital & Healthcare Services | Small Cap | Dr Agarwals Eye Hosp Share Price
₹5,310 -5.75 (-0.11%)
As on 11-Sep'26 15:14
Dr Agarwals Eye Hospital Ltd (DRAGARWQ)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 526783 NSE: DRAGARWQ Hospital & Healthcare Services | Small Cap | Dr Agarwals Eye Hosp Share Price
₹5,310 -5.75 (-0.11%)
As on 11-Sep'26 15:14
Key Metrics
Valuation Multiples
Market Cap
₹2,569 Cr.
Current Price
₹5,310
52-Week Low / High
₹4,412 / 6,392
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
100.8
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
18.56%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
72.67%
Pledged shares (%) of Promoter's holding (%)
7.67%
Reserves
-
Equity
₹4.8 Cr.
Face Value
₹10
All Time Low / High
₹2.10 / 7300.00
Check Before You Invest
Quality
Not GoodValuation
Somewhat OvervaluedCheck Valuation charts
Price Trend
Semi Strong
Is Dr Agarwals Eye Hospital Ltd a good quality company?
Dr Agarwals Eye Hospital Ltd is a good quality company, based on a consistently good multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Dr Agarwals Eye Hospital Ltd performance compare with that of its Peers?
Revenue growth of Dr Agarwals Eye Hospital Ltd vs industry peers?
Dr Agarwals Eye Hospital Ltd revenue CAGR is 27.49%, compared to the industry median CAGR of 2.87%, indicating faster growth and gaining its market share.
Promoter shareholding and pledge status of Dr Agarwals Eye Hospital Ltd?
Promoters hold 72.67% of the Dr Agarwals Eye Hospital Ltd, with 7.67% of their stake pledged, indicating low pledge risk.
Stock return of Dr Agarwals Eye Hospital Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 38.7% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Dr Agarwals Eye Hospital Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 28.3% | 31.7% | 34.3% | 39.9% | 16.9% | 42.4% | 43% | 38.6% | 33.3% | 29.2% | - |
| Value Creation Index ⓘ | 1.0 | 1.3 | 1.5 | 1.9 | 0.2 | 2.0 | 2.1 | 1.8 | 1.4 | 1.1 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 149 | 153 | 170 | 176 | 140 | 201 | 268 | 319 | 397 | 471 | 497 |
| Sales YoY Gr. | - | 3.2% | 10.9% | 3.5% | -20.5% | 43.9% | 33.2% | 19.1% | 24.4% | 18.6% | - |
| Adj EPS ⓘ | 16.2 | 14.5 | 25.3 | 29.3 | -3 | 51 | 78.7 | 99 | 115.3 | 143.9 | 157.7 |
| YoY Gr. | - | -10.5% | 74.2% | 15.7% | -110.3% | NA | 54.4% | 25.8% | 16.5% | 24.7% | - |
| BVPS (₹) ⓘ | 62.6 | 74.6 | 97 | 119.4 | 116.3 | 166.3 | 241.2 | 334.4 | 446 | 717 | 764.9 |
| Adj Net Profit ⓘ | 7.6 | 6.8 | 11.9 | 13.8 | -1.4 | 24 | 37 | 46.5 | 54.2 | 69.5 | 76 |
| Cash Flow from Ops. ⓘ | 20.1 | 18.6 | 25.1 | 38.6 | 33.9 | 56.7 | 69.6 | 89.8 | 93.6 | 145 | - |
| Debt/CF from Ops. ⓘ | 1.2 | 1 | 1 | 0.5 | 0.6 | 0.6 | 0.6 | 0.6 | 1 | 0.6 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 13.7% | 27.5% | 20.7% | 18.6% | ||||
| Adj EPS ⓘ | 27.4% | NA | 22.3% | 24.7% | ||||
| BVPSⓘ | 31.1% | 43.9% | 43.8% | 60.8% | ||||
| Share Price | 38.8% | 67% | 29.4% | 14.5% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 28.9 | 21.2 | 29.5 | 27.1 | -2.6 | 36.1 | 38.6 | 34.4 | 29.6 | 25 | 21.3 |
| Op. Profit Mgn % ⓘ | 15.2 | 15.9 | 17.6 | 26.9 | 21.4 | 29.2 | 28.3 | 28.9 | 30.1 | 31.1 | 30.5 |
| Net Profit Mgn % ⓘ | 5.1 | 4.5 | 7 | 7.8 | -1 | 11.9 | 13.8 | 14.6 | 13.7 | 14.8 | 15.3 |
| Debt to Equity ⓘ | 0.8 | 0.5 | 0.5 | 0.3 | 0.4 | 0.4 | 0.4 | 0.3 | 0.5 | 0.2 | - |
| Working Cap Days ⓘ | 112 | 117 | 124 | 131 | 150 | 103 | 92 | 94 | 104 | 108 | 50 |
| Cash Conv. Cycle ⓘ | -19 | -23 | -22 | -10 | -15 | -30 | -32 | -26 | -15 | -7 | 11 |
Valuation of Dr Agarwals Eye Hosp - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 55.45 | 55.45 | 55.45 | 55.45 | 29.26 | 29.26 | 29.26 | 7.67 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Dr Agarwals Eye Hospital Ltd FAQs
The current trading price of Dr Agarwals Eye Hosp on 11-Sep-2026 15:14 is ₹5,310.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 10-Sep-2026 the market cap of Dr Agarwals Eye Hosp stood at ₹2,569 Cr
The latest P/E ratio of Dr Agarwals Eye Hosp as of 10-Sep-2026 is 33.71.
The latest P/B ratio of Dr Agarwals Eye Hosp as of 10-Sep-2026 is 6.95.
The 52-week high of Dr Agarwals Eye Hosp is ₹6,392 and the 52-week low is ₹4,412.1.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Dr Agarwals Eye Hosp is ₹497 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Dr Agarwals Eye Hospital Ltd is a below average quality company.
The key valuation ratios of Dr Agarwals Eye Hospital Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Dr Agarwals Eye Hospital Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.
About Dr Agarwals Eye Hospital Ltd
Dr Agarwal’s Eye Hospital, founded in 1957 and registered in 1994 as a Company, is a leading chain of eye hospitals with predominant presence in Tamil Nadu. Under the able leadership of Dr Amar Agarwal, the company has been a pioneer and leader in the Ophthalmology market with an established market position and healthy brand recall in the eye care segment. It offers comprehensive services in the eye-care segment including Cataract, Glaucoma, Laser Correction, Cornea and Refractive, Retina, and Squint among others. The company provides comprehensive services across all major ophthalmic specialities. It offers comprehensive services in the eye-care segment including Cataract, Glaucoma, Laser Correction, Cornea and Refractive, Retina, and Squint among others. The hospital uses advanced diagnostic technology, precision surgical systems and global best practices to ensure accurate treatment outcomes. Each speciality is supported by dedicated teams trained in complex procedures and emerging innovations.
Business area of the company
Dr Agarwals Eye Hospital is primarily engaged in running, owning and managing eye care hospitals, opticals, pharmacies, etc. and related services.
Eye Treatments & Surgery
- Trabeculectomy Surgery for Glaucoma
- Glaucoma Shunt Surgery
- Silk LASIK
- Laser Trabeculoplasty for Glaucoma Treatment
- YAG Peripheral Iridotomy (YAG PI)
- Minimally Invasive Glaucoma Surgery (MIGS)
- Robotic Cataract
- Central Serous Retinopathy (CSR)
- Hyperopia
- Stye Eye Treatment
- Refractive Surgery
- Myopia
- Contoura Lasik
- Lasik Surgery
- Flapless LASIK
- Photorefractive Keratectomy (PRK)
- Implantable Collamer Lens (ICL)
- Eyelid & Eye Socket Correction (Oculoplasty)
- Glued IOL
- CAIRS Eye Surgery
- Advanced Corneal Transplant (PDEK)
- Pneumatic Retinopexy (PR)
- Cornea Transplantation
- Pinhole Pupilloplasty
- Paediatric Ophthalmology
- Cryopexy
- Retina Injection Therapy (Anti-VEGF)
- Cosmetic Eye Surgery
- Dry Eye Treatment
- Retinal Laser Photocoagulation
- Retina Repair Surgery (Vitrectomy)
- Scleral Buckle
- Laser Cataract Surgery
- Black Fungus Treatment & Diagnosis
- Neuro Ophthalmology
You have 32 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
